Literature DB >> 16322836

[Ocular open trauma: characteristics of admitted cases at the Padre Bento Hospital of Guarulhos, SP].

Mônica Weyll1, Regina Cele Silveira, Nilson Lopes da Fonseca Júnior.   

Abstract

PURPOSE: This study tends to identify the incidence of ocular open trauma at the emergency service of the "Complexo Hospitalar Padre Bento of Guarulhos, SP".
METHODS: It is a descriptive transversal study performed in a period of four months at the "Complexo Hospitalar Padre Bento". All patients admitted at the emergency room with a diagnosis of open ocular trauma were included. After ophthalmologic examination, all patients hospitalized, with intravenous antibiotic therapy, occlusive tamper and preparation for surgery.
RESULTS: Twenty-three patients with ocular perforating trauma were attended. Mean age was 34.35 years, with males representing 87.00% of all cases. Motor vehicle accidents were the most frequent type of trauma with 43.50% of the patients. Visual acuity loss was an important predictor of looking for early medical emergency service, with 92.30% of the patients doing this in less than twelve hours.
CONCLUSION: Penetrating corneal trauma was the most frequent. Open ocular trauma was more frequent in young men, victims of automobile accident. The right eye was the most affected. Low vision was the mostly observed immediate complication.

Entities:  

Mesh:

Year:  2005        PMID: 16322836     DOI: 10.1590/s0004-27492005000400015

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  2 in total

1.  Ischemic retinopathy and neovascular proliferation secondary to severe head injury.

Authors:  Muge Coban-Karatas; Rana Altan-Yaycioglu
Journal:  Case Rep Ophthalmol Med       Date:  2014-07-20

2.  Epidemiology and prognosis factors in open globe injuries in the Federal District of Brazil.

Authors:  Marina Berquó Peleja; Felipe Bruno Santos da Cunha; Mariana Berquó Peleja; Juliana Tessari Dias Rohr
Journal:  BMC Ophthalmol       Date:  2022-03-09       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.